Target intelligence / Profile preview

MicroRNA 539 (miR-539)

Target
miR-539
Molecular classification
microRNA, Non-coding RNA, RNA gene
01

Overview

MicroRNA 539 is a member of the microRNA family: small (20–24 nucleotides), non-coding RNA sequences that regulate gene expression by targeting mRNAs for degradation or translational repression. miR-539 functions primarily as a tumor suppressor across a wide spectrum of solid tumors and some non-malignant diseases. Its mechanism involves binding to specific gene transcripts such as EGFR, IGF-1R, SOX5, FSCN1, and others, leading to reduced protein output of those oncogenes and resultant cancer cell growth inhibition, apoptosis, and reduction of metastatic behavior. miR-539 levels are often decreased in tumors, and restoration of its expression in preclinical models leads to dramatic reductions in tumor growth and invasiveness.

Other names
MIR539hsa-mir-539mir-539MIRN539
02

Mechanism of action

Restoration of miR-539 expression inhibits tumor cell growth and migration, promotes cancer cell apoptosis, and sensitizes drug-resistant cancer cells to chemotherapy.

03

Biological functions

Post-transcriptional regulation of gene expressionInhibition of cell proliferationPromotion of apoptosisSuppression of migration and invasionModulation of metastasisRegulation of cellular ferroptosisRegulation of immune activation
04

Disease associations

CancerAutism spectrum disorderLynch syndrome 2Heart failure
05

Safety considerations

Off-target effects of miRNA therapeuticsDelivery and stability of miRNA mimics or inhibitors in vivoInsufficient data on safety for miR-539-specific therapies
06

Interacting drugs

Arsenic trioxide
07

Biomarkers

miR-539 downregulation (correlated with advanced disease stage and lymph node metastasis in multiple cancers)Cellular levels of miR-539 (diagnostic/prognostic markers in cancer)

Beyond the preview

Go deeper on MicroRNA 539 (miR-539).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 539 (miR-539).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call